机构:[1]Southern Univ Sci & Technol, Sch Life Sci, Dept Biol, Shenzhen, Peoples R China[2]Peking Univ Shenzhen Hosp, Dept Lab Med, Shenzhen, Peoples R China[3]Hong Kong Baptist Univ, Inst Integrated Bioinfomed & Translat Sci IBTS, Sch Chinese Med, Hong Kong, Peoples R China[4]Shanghai Acad Tradit Chinese Med, Inst Arthrit Res Integrat Med, Shanghai, Peoples R China[5]Guangdong Hong Kong Macau Joint Lab Chinese Med &, Guangzhou, Peoples R China[6]Beijing Inst Lifeom, Natl Ctr Prot Sci Beijing, State Key Lab Prote, Beijing, Peoples R China
The CRISPR/Cas systems in prokaryotes such as bacteria and archaea are the adaptive immune system to prevent infection from viruses, phages, or other foreign substances. When viruses or phages first invade the bacteria, Cas proteins recognize and cut the DNA from viruses or phages into short fragments that will be integrated into the CRISPR array. Once bacteria are invaded again, the modified CRISPR and Cas proteins react quickly to cut DNA at the specified target location, protecting the host. Due to its high efficiency, versatility, and simplicity, the CRISPR/Cas system has become one of the most popular gene editing technologies. In this review, we briefly introduce the CRISPR/Cas systems, focus on several delivery methods including physical delivery, viral vector delivery, and non-viral vector delivery, and the applications of disease therapy. Finally, some problems in CRISPR/Cas9 technology have been proposed, such as the off-target effects, the efficiency of DNA repair mechanisms, and delivery of CRISPR/Cas system safely and efficiently to the target location.
基金:
National Natural Science Foundation Council of China; Department of Education of Guangdong Province [82172386, 81922081, 82104216]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2021KTSCX104]; Guangdong Basic and Applied Basic Research Foundation [2020B1212030006]; Science, Technology and Innovation Commission of Shenzhen [2020A1515011450, 2022A1515012164]; [JCYJ20210324104201005]; [JCYJ20190809094007719]
第一作者机构:[1]Southern Univ Sci & Technol, Sch Life Sci, Dept Biol, Shenzhen, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Southern Univ Sci & Technol, Sch Life Sci, Dept Biol, Shenzhen, Peoples R China[3]Hong Kong Baptist Univ, Inst Integrated Bioinfomed & Translat Sci IBTS, Sch Chinese Med, Hong Kong, Peoples R China[4]Shanghai Acad Tradit Chinese Med, Inst Arthrit Res Integrat Med, Shanghai, Peoples R China[5]Guangdong Hong Kong Macau Joint Lab Chinese Med &, Guangzhou, Peoples R China[6]Beijing Inst Lifeom, Natl Ctr Prot Sci Beijing, State Key Lab Prote, Beijing, Peoples R China
推荐引用方式(GB/T 7714):
Huang Jie,Zhou Yitong,Li Jie,et al.CRISPR/Cas systems: Delivery and application in gene therapy[J].FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY.2022,10:doi:10.3389/fbioe.2022.942325.
APA:
Huang, Jie,Zhou, Yitong,Li, Jie,Lu, Aiping&Liang, Chao.(2022).CRISPR/Cas systems: Delivery and application in gene therapy.FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY,10,
MLA:
Huang, Jie,et al."CRISPR/Cas systems: Delivery and application in gene therapy".FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY 10.(2022)